Robert Gallotto is listed as an executive officer on 3 SEC Form D filings by 2 issuers between Feb 2010 and Oct 2016: Alcresta Therapeutics, Inc. (Warren, NJ — biotechnology — 2016; $50.9M reported sold to 19 investors) and ALNARA PHARMACEUTICALS INC (Cambridge, MA — pharmaceuticals — 2010; $20M reported sold to 9 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 6 years. Across those companies the filings report $70.9M sold in total.
Listed alongside Alexey Margolin (3 shared filings), James Topper (3 shared filings), Daniel Tasse (2 shared filings), Jeremy Lack (2 shared filings), Stephen Krauss (2 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Robert Gallotto and found 3 differences, 1 worth asking the sponsor about: Form D filed 84 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.